NeXT Personal™
NeXT Personal™ The Next Generation in Molecular Residual Disease Testing and Variant Monitoring for Solid Tumors Delivering Industry-Leading Sensitivity to Detect Residual Disease and Recurrence at the Earliest Timepoints NeXT Personal, an advanced, personalized, and tumor-informed liquid biopsy assay, is designed to detect molecular residual disease (MRD) and cancer recurrence at [...]